Boundless Bio Operating Income

Boundless Bio (BOLD) currently reports a operating income of $-68M as of June 2026. That compares with $-71M in the prior-year period — up 4.7% year over year. Use the charts on this page to explore Boundless Bio's operating income history and peer comparisons.

Boundless Bio's operating income increased from $-71M to $-68M — a 4.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Boundless Bio reported $-68M in operating income as of June 2026. That compares with $-71M in the prior-year period — up 4.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-68M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Boundless Bio, and consider following BOLD for alerts when major investors trade the stock.